Toft Group Welcomes Julie Visser as Executive Career Coach and Executive Search Leader

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, announced Julie Visser has been appointed as Toft Group’s Executive Career Coach and Executive Search Leader. Ms. Visser has more than 20 years of expertise in talent acquisition, executive C-Suite placements and executive career coaching. She will oversee Toft Group’s corporate executive career coaching initiative and continue to build executive search assignments for both C-Suite talent and Board member positions. 

“Demand for top talent, particularly qualified diverse candidates, is at an all-time high as healthcare companies recognize a talent gap has emerged, and companies recognize the competitive advantage of an inclusive executive team complimented by an inclusive Board of Directors,” said Ron Giannotti, President and CEO of Toft Group.  “I am thrilled with the addition of Julie’s talent to our Toft Team! Her knowledge will play a key role in expanding our life science executive search practice. In addition, Julie brings the experience and know-how to build a premier coaching practice which is a key component of the soon to be released WE CAN™ Platform that enables female candidates to prepare and accelerate their careers.”

Prior to joining Toft Group, Ms. Visser enjoyed a career leading and partnering with US companies’ worldwide human resource efforts, including Life Technologies, Thermo Fisher and NuVasive. Her expertise in talent acquisition and executive global placement has resulted in countless job opportunities for those seeking advancement in their careers. In addition, Ms. Visser is the founder of JA Talent Partners, a career coaching company, focused on women re-entering the workforce.  

Ms. Visser holds a bachelor’s degree in marketing management from the University of Arizona and is AIRS certified.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies at the intersection of biotech and high tech. Toft Group’s targeted, accurate searches translate into exceptional return-on-investment for clients nationwide, and the team’s extensive networks enable the presentation of more highly qualified and diverse candidates than clients would otherwise see. The firm’s extensive track record has shown its ability to quickly fill highly specialized leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Diego, San Francisco and Boston.

Toft Group Executive Search Places Ellen Lubman on Board of Advisors at TMRW Life Sciences, Inc. in New York, NY

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Ellen Lubman on Board of Advisors at TMRW Life Scienc

As Chief Business Officer of Impel Neuropharma, Ms. Lubman leads corporate development activities and strategy for the private neuroscience therapeutics company.

Prior to joining Impel, she served as the Vice President of External Science & Innovation at Allergan, where she was responsible for strategic expansion of the company’s pipeline in a variety of disease areas, including women’s health. 

“We are thrilled to have Ellen join our Advisory Board,” said Alan Murray, TMRW’s Founder and Co-CEO. “Her deep interest in and understanding of the assisted reproductive technology landscape and her experience as a senior leader at life sciences companies at every stage of development make her an ideal advisor for TMRW, especially regarding strategic partnering and financing initiatives.”

Ms. Lubman has 20 years of biopharmaceutical corporate development and Wall Street industry experience, including roles at Kadmon Pharmaceuticals, Bristol-Myers Squibb, Celtic Pharma Management, L.P. and Robertson Stephens. She is a member of the Board of Directors of Dauntless Pharmaceuticals and GeneCentric Therapeutics.

About TMRW

In coming decades, a rapidly scaling fertility industry and increased access to IVF therapies will be responsible for nearly 300 million global births — almost all of which will rely upon frozen fertility cells. To meet this rapidly growing demand, TMRW has created the first fully Robotic Process Automation (RPA) platform designed specifically for IVF. Already experiencing rapid market adoption, TMRW is poised to become the global standard for cryo-preservation and fertility cell management. IVF clinicians have embraced TMRW’s RPA platform because it replaces an outdated analog IVF cryo-management function with proven risk-mitigating Robotic Process Automation technology.

TMRW provides the world’s first complete RFID cryo-temperature compatible digital chain of custody for all fertility cells—including embryos and gametes. TMRW software is constantly vigilant and automates 17,000 daily environmental “health checks” that ensure the safety and security of the world’s most precious cells.

TMRW’s co-founders, Joshua Abram, Alan Murray and Dr. Jeff Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Executive Search Places Chris Cournoyer on Board of Directors for CareDx, Inc. in Brisbane, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Chris Cournoyer on the Board of Directors for CareDx, Inc. in Brisbane, CA. 

“Chris brings deep experience in technology and her recent experiences with EHR and CDS solutions will be invaluable,” comments Peter Maag, CareDx Chief Executive Officer, “as we build out our offerings in Digital Transplant Solutions.”

Cournoyer was previously the Chairperson and Chief Executive Officer for N-of-One. N-of-One is a leader in precision medicine delivering clinical and molecular decision support for targeted therapies decisions based on a cancer patient’s molecular profile. Prior, she was the Vice President of Clinical Analytics at Optum, through the acquisition of Picis where she was the President and COO. At Optum and Picis, Cournoyer was responsible for clinical EHR solutions and clinical decision support (CDS) solutions. Cournoyer has also held roles at Harte Hanks, Lotus, and IBM. At Lotus she was the Chief Information Officer. At IBM she was Vice President of Global Business Transformation responsible for driving the digital strategy for global software fulfillment for the $8B software business. 

Ron Giannotti, President and CEO of Toft Group said: “CareDx is an exceptionally innovative company with an incredibly strong leadership team.  Chris will add significant value to the organization, and will be a strong contributor to the future growth of the company.”

She has provided technology expertise and guidance on the digital strategy for three public boards including Stride Rite, GTECH, and BJ’s Wholesale group, and has been a director for Emerson Hospital. Cournoyer holds a B.S in Business Administration, University of Massachusetts, an MA in Economics, Northeastern University and has attended MIT ‘s Executive Education Program.

“I look forward to bringing my experiences to impact care for transplant patients. CareDx is well positioned to be the data leader in transplant, and I am excited to join the board working closely with the management team to positively impact patients’ lives,” said Chris Cournoyer.

About CareDx

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Executive Search Places Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY.

Lori Batta was previously Chief Commercial Officer at Celmatix, Inc., a next generation women’s health company. Prior to Celmatix, Batta served as Senior Vice President, Business Development and Strategic Alliances at Good Start Genetics (GSG), where she led the company’s global business development strategy. During her time at GSG, Batta was responsible for the launch of the first next-generation sequencing carrier screen and drove more than $100M in revenue in its first three years in the market. 

Batta also served as Senior Director, Commercial with Javelin Pharmaceutical, where she directed regulatory and commercialization strategy for the Javelin Pain Franchise for three late-stage specialty pain products. Before Javelin, she served as Vice President of Sales and Marketing for MDR Specialty Pharma, and Vice President of Sales, Reproductive Health for EMD Serono.

Batta holds a B.A. in Biology from College of St. Elizabeth, Convent Station, NJ.

About TMRW
In coming decades, a rapidly scaling fertility industry and increased access to IVF therapies will be responsible for nearly 300 million global births—almost all of which will rely upon frozen fertility cells. To meet this rapidly growing demand, TMRW has created the first fully Robotic Process Automation (RPA) platform designed specifically for IVF. Already experiencing rapid market enthusiasm, TMRW is poised to become the global standard for cryo-preservation and fertility cell management. IVF clinicians have embraced the concept of TMRW’s risk-mitigating RPA platform as a replacement for current less sophisticated analog IVF cryo-management systems. TMRW provides the world’s first complete RFID cryo-temperature compatible digital chain of custody for all fertility cells—including embryos and gametes. TMRW software is constantly vigilant and automates 17,000 daily environmental “health checks” that ensure the safety and security of the world’s most precious cells.

TMRW’s co-founders, Joshua Abram, Alan Murray and Dr. Jeff Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion. www.tmrw.org 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Places Peg Taylor as Vice President, Clinical Operations at Adicet Bio, Inc. in Menlo Park, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Peg Taylor as Vice President, Clinical Operations at Adicet Bio, Inc. in Menlo Park, CA.

Peg Taylor most recently served as Senior Director, Clinical Operations at Nektar Therapeutics. Previously, she served in progressive clinical roles at Genentech, most recently as Program Group Director. There, she led the program execution of all Clinical Operations for a portfolio of molecules in early development.

Prior to Genentech, Taylor was Senior Director at Bayhill Therapeutics where she led clinical operations for a virtual biotech company focused on autoimmune disease assets. Earlier, she served as Oncology Clinical Program Director for Quintiles (now IQVIA), where she supported various studies focused on tumors including NSCLC, Glioblastoma, GI Stromal Tumors and MBC. 

Taylor holds a B.S. in Nutrition Science from University of California, Davis.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. Adicet is developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors or T Cell Receptors (TCRs). Adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating TCR-like MAbs (TCRLs) directed to these cancer-specific peptide targets presented by MHC Class I complexes. In August 2016, Adicet entered a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop next-generation engineered immune-cell therapeutics using Adicet’s gamma delta T cell allogeneic platform technology. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Successfully Places Jessica M. Riley, Ph.D. as Vice President of Companion Diagnostics at PathAI in Boston, MA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jessica M. Riley, Ph.D. as Vice President of Companion Diagnostics at PathAI in Boston, MA.

Dr. Jessica Riley served as Senior Director, Business Development at Guardant Health where she led business collaborations with Pharmaceutical companies for the development and commercialization of Next Generation Sequencing Liquid Biopsy products, as well as Companion Diagnostic programs. She joined Guardant from Leica Biosystems where she served as Senior Director, Business Development, Pharma Partnerships. Previously, Dr. Riley held progressive roles with Qiagen, most recently as Director of Assay Development. 

Dr. Riley’s career began at St. James’s University Hospital as a Clinical Genetics Scientist. She holds a Ph.D. in Bio-production & Characterization of Self-Assembling Peptides from the University of Leeds, UK, and a B.S in Molecular & Cellular Biology from the University of Huddersfield, UK.

About PathAI
PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Successfully Places Jon Buncab as Vice President Market Access at Millennium Health in San Diego, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jon Buncab as Vice President Market Access at Millennium Health in San Diego, CA.

Jon Buncab has served as Senior Director of Market Access and Reimbursement Strategy at Genoptix where he was responsible for payer, health system and laboratory support of their oncology portfolio, implementing strategic expertise regarding market access and reimbursement. Notably, he contributed to the successful launch of the MRDx® BCR-ABL Test, the first companion diagnostic promoted by Genoptix.

Previously, Buncab was Executive Director, Head of Payer Strategy, Reimbursement and Client Operations at Prometheus Laboratories. There, he led market access field teams in therapeutic and diagnostic payer, health system, hospital and laboratory strategy for both gastroenterology and oncology product portfolios and client operations. He also served as Director of Managed Care West for CardioDx, establishing diagnostic medical policy and managed care contracts for Corus CAD® in the West Region. Before that, he was the National Director, Managed Markets/Sales for Exagen Diagnostics, where he led field sales for this rheumatology specialty company focused on unmet needs. 

About Millennium Health
Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically actionable information through our nationwide medication monitoring and drug testing services. Drug testing is used by substance use disorder and pain management providers to obtain objective information about patients’ recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment plans. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Robin Toft’s WE CAN: The Executive Woman’s Guide to Career Advancement Recognized Within List of 100 Best CEO Books of All Time by BookAuthority

The best CEO books of all time
SAN FRANCISCO, July 9, 2019 Toft Group Executive Search, a global life sciences and healthcare executive search firm, today announced that its Chairman and CEO, Robin Toft, has been recognized on BookAuthority’s list of 100 Best CEO Books of All Time for her recently launched professional development book titled WE CAN: The Executive Woman’s Guide to Career Advancement. WE CAN provides valuable insights to empower women to quickly navigate to the career of their dreams. 

“I am incredibly honored to have made this prestigious list of best CEO books of all time,” said Robin Toft. “This recognition as one of the best books for professional development highlights my aspiration to empower women in their lives to achieve their dreams.”

The full list of 100 Best CEO Books of all time can be found here, and WE CAN: The Executive Woman’s Guide to Career Advancement can be purchased on Amazon.

As featured on CNN, Forbes and Inc, BookAuthority is the world’s leading site for nonfiction book recommendations for the best books for personal development. BookAuthority uses a proprietary technology to identify and rate the best nonfiction books, using dozens of different signals, including public mentions, recommendations, ratings, sentiment, popularity and sales history. This includes maintaining the most comprehensive collection of book recommendations from domain experts such as Elon Musk, Warren Buffett, Prof. Daniel Kahneman, Sheryl Sandberg, and David Allen.

About WE CAN

Becoming an executive is no easy task. Becoming a female executive is something else altogether. How can the ambitious woman excel, advance, and thrive in seemingly male-dominated industries with thousands of years of history working against her?

Through her own inspiring journey from employee to powerful female executive, Robin Toft shares the wisdom she gleaned at the boardroom table as an executive with over a decade of experience in executive search as Founder and CEO of the award-winning Toft Group. No matter where you are on your executive journey, Robin Toft will move you to action and empower you as a trusted partner through every aspect of your career advancement. Part manual and part memoir, WE CAN provides the confidence, language, and tools to design and realize the career of your dreams. Land the job, make vertical moves, and secure a seat at the boardroom table.

About Robin Toft

Upon founding Toft Group in 2010, Robin essentially launched a second career, following more than two decades as a biotech executive. She was awarded Woman of the Year in San Diego in 2017, in 2018 and 2019 she was a finalist in Ernst & Young’s prestigious Entrepreneur of the Year awards, and she’s been honored as a finalist for San Diego Business Journal’s “Women Who Mean Business” and “Most Admired CEO” awards in multiple years. Robin’s work with Toft Group combines a deep inside knowledge of the life science industry with a passion for building game-changing management teams.

About Toft Group Executive Search

Toft Group is a global life sciences and healthcare executive search firm specializing in diversity and a focus on innovation-driven companies at the intersection of biotech and high tech. Toft Group’s targeted, accurate searches translate into exceptional return-on-investment for clients nationwide, and the team’s extensive networks enable the presentation of more highly qualified and diverse candidates than clients would otherwise see. The firm’s extensive track record has shown its ability to quickly fill highly specialized leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Diego, San Francisco and Boston. For more information, please visit thetoftgroup.com.

Toft Group Executive Search Places Patricia Sandler as National Sales Director at OPKO Health, Inc. in Miami, FL

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Patricia Sandler as National Sales Director at OPKO Health, Inc. in Miami, FL.

Ms. Sandler previously served as Field Vice President at GlaxoSmithKline (GSK) overseeing a large team, promoting their respiratory inhaler portfolio. Before GSK, Sandler led commercial operations at Omeros Corporation, managing the comprehensive reimbursement support program and launch. She also previously held progressive commercial roles at Sunovion Pharmaceuticals, including Sales Team Lead for the respiratory portfolio, Interim Marketing Lead managing a product launch and prior as Executive Director, CNS Marketing for Lunesta brand.  Sandler also drove marketing and sales activities within the gastroenterology portfolio at Johnson & Johnson.

Sandler holds a BS. in business administration from Bloomsburg University of Pennsylvania.

About OPKO Health, Inc.
OPKO Health is a diversified healthcare company. In diagnostics, its BioReference Laboratories is the nation’s third largest clinical laboratory; GeneDx is a rapidly growing genetic testing business; the 4Kscore® prostate cancer test is used to confirm an elevated PSA to help decide about next steps such as prostate biopsy; Claros® 1 is a point-of-care diagnostics platform with a total PSA test approved by the FDA and testosterone as the most advanced test in development. In the pharmaceutical pipeline, RAYALDEE is their first pharmaceutical product to be marketed.  OPK88003, a once-weekly oxyntomodulin for type 2 diabetes and obesity recently reported positive data from a Phase 2 clinical trial.  It’s among a new class of GLP-1/glucagon receptor dual agonists.  OPK88004, a SARM (selective androgen receptor modulator) is currently being studied for various potential indications.  The Company’s most advanced product utilizing its CTP technology, a once-weekly human growth hormone for injection, is in Phase 3 trials, and is partnered with Pfizer.  OPKO also has research, development, production and distribution facilities abroad.  

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Successfully Places Grace Colón, Ph.D. on Board of Directors for CareDx, Inc. in Brisbane, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Grace Colón, Ph.D, on the Board of Directors for CareDx, Inc. in Brisbane, CA.

Dr. Colón has served as President, Chief Executive Officer and Director of InCarda Therapeutics, Inc., a clinical stage company developing therapeutics for cardiovascular conditions since 2013. In addition to her role at InCarda, she is also Executive Chairman (formerly CEO) of ProterixBio and is on the board of Cocoon Biotech. Previously, she served on the boards of Paradigm Diagnostics and PerceptiMed. She was formerly a partner at New Science Ventures and held various leadership roles at Intrexon Corporation, Gilead Sciences and Affymetrix. Earlier in her career, she was an engagement manager with McKinsey & Co.

Dr. Colón is a native of San Juan, Puerto Rico. She received her Ph.D. in chemical engineering from the Massachusetts Institute of Technology, where she conducted doctoral and post-doctoral research on metabolic engineering of industrial amino acids. She also holds a B.S. degree in chemical engineering from the University of Pennsylvania, where she was a Benjamin Franklin Scholar.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum and is the leading provider of genomics-based information for transplant patients.

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.